Is Idera Pharmaceuticals a good stock to buy?
Idera Pharmaceuticals Inc (NASDAQ:IDRA) The 1 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +57.58% increase from the last price of 0.63.
What happened to Idera Pharmaceuticals?
Shares of Idera Pharmaceuticals (NASDAQ: IDRA) were crashing 63.5% at 10:49 a.m. EDT on Friday. The plunge came after the company announced disappointing results Thursday from a late-stage study of tilsotolimod in combination with Bristol Myers Squibb’s Yervoy in treating advanced melanoma.
Is Idera a pharmaceutical?
Idera Pharmaceuticals is a clinical-stage biopharmaceutical company located in the western Philadelphia suburb of Exton. We are passionately focused on the development and commercialization of our proprietary immune modulator, tilsotolimod, for the treatment of cancer.
Is Idera a public company?
It is headquartered in Houston, Texas and has offices in Australia, Austria, and the United Kingdom. It is owned by the private equity firms HGGC, Partners Group and TA Associates. Idera, Inc….Idera, Inc.
| Formerly | BBS Technologies |
|---|---|
| Key people | Randy Jacops (CEO) Steve Young (Chairman) |
| Parent | HGGC Partners Group TA Associates |
How do I buy Idra stock?
Shares of IDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Is Idra public?
An independent, private non-profit organization, IDRA works with thousands of K-12 educators, and family, community and higher education partners to…
Who owns Idera Inc?
Partners Group
HGGCTA Associates
Idera, Inc./Parent organizations
How many employees does Idera Inc have?
525 total
Company Description: Idera, Inc. is located in Austin, TX, United States and is part of the Computer Systems Design and Related Services Industry. Idera, Inc. has 525 total employees across all of its locations and generates $284.59 million in sales (USD). (Sales figure is modelled).
Who makes Giga press?
Idra
Tesla put its first Giga Press into operation at the Fremont factory in 2020. Made by the Italian firm Idra, it has a clamping force of 55,000 to 61,000 kilonewtons (5,600 to 6,200 tons of force). The company uses it to produce front and rear underbody castings for Model Y.
What happened to EG Idra?
He is currently sponsored by Tt eSports. After a retirement to focus on school, he has returned to former team Evil Geniuses for Heroes of the Storm. IdrA is known for his macro abilities and an excellent grasp of fundamentals and mechanics.
What do you know about Idera?
Idera, Inc. brands span three divisions – Database Tools, Developer Tools, and Test Management Tools – with products that are evangelized by millions of community members and more than 50,000 customers worldwide, including some of the world’s largest healthcare, financial services, retail, and technology companies.
How much is Tesla Giga Press?
Tesla reportedly already started casting the Model Y in two large pieces using a 6,000-ton Giga Press, which is an industry first. However, new reports suggest a 12,000-ton Giga Press is in the works, and it might be able to cast the upcoming $25,000 Tesla compact car in a single piece.
What is Idera Pharmaceuticals?
? Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States.
How much is Idera stock worth?
One share of IDRA stock can currently be purchased for approximately $0.80. How much money does Idera Pharmaceuticals make? Idera Pharmaceuticals has a market capitalization of $42.24 million and generates $1.45 million in revenue each year.
What is the upside for Idera Pharmaceuticals’stock?
Their forecasts range from $1.00 to $2.00. On average, they expect Idera Pharmaceuticals’ share price to reach $1.50 in the next twelve months. This suggests a possible upside of 87.5% from the stock’s current price.
Is Idera Pharmaceuticals’s PE (Idera) ratio positive or negative?
Only 11.67% of the stock of Idera Pharmaceuticals is held by institutions. The P/E ratio of Idera Pharmaceuticals is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.